Pharming Group to Present at September Investor Conferences
News related to:Pharming Group N.V · 1 min read
Pharming Group, a global biopharmaceutical company based in Leiden, the Netherlands, will present at two major investor conferences in September 2026. The management team, led by Chief Executive Officer Fabrice Chouraqui, will participate in these events, offering insights into the company’s strategic plans and progress.
On Monday, September 14, 2026, Chouraqui will deliver a presentation at the H.C. Wainwright 28th Annual Global Investment Conference in New York. The session is scheduled to begin at 09:30 Eastern Daylight Time (15:30 Central European Summer Time). A live webcast and a replay of the presentation will be available on Pharming’s website under the “Events and presentations” and “Our news” sections.
Pharming Group is dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases by developing and commercializing innovative medicines, including small molecules and biologics. The company’s presence at these conferences underscores its commitment to engaging with the investment community and sharing its progress in the pharmaceutical sector.